Yhn ScienceBiology first seen 1 d ago, last 39 min ago, peak #5
Novo Nordisk and Eli Lilly report GLP-1 signals of slowed biological aging
Original: Novo Nordisk, Eli Lilly Report GLP-1 Signals of Slowed Biological Aging at ARDD
Novo Nordisk and Eli Lilly presented findings at the Aging Research and Drug Discovery (ARDD) meeting suggesting that GLP-1 drugs, best known for diabetes and weight loss, show signals of slowed biological aging. If confirmed, the findings would expand the potential uses of these blockbuster medications beyond metabolic disease into longevity medicine.
Why now: GLP-1 drugs are already hugely popular, and evidence they may slow aging would dramatically broaden their appeal and market
Novo NordiskEli LillyARDDGLP-1 drugs
Rank over time, top of the chart is #1. 57 snapshots from 1 d ago to 39 min ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/2933411